Which policy for new psychoactive drugs?

Uchtenhagen, Ambros

doi:10.1111/add.13478

Addiction

2016

DOI: 10.1111/add.13478

|View full text |Cite

Which policy for new psychoactive drugs?

Ambros Uchtenhagen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2016

2019

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(2 citation statements)

References 14 publications

(11 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Uchtenhagen reiterates [5]. More troublesome is that a blanket ban ignores the full scope of the problem, namely the drivers behind demand for these substances.…”

mentioning

confidence: 99%

“…More troublesome is that a blanket ban ignores the full scope of the problem, namely the drivers behind demand for these substances. Uchtenhagen alludes to the fact that benefits are absent in the discussion of regulation of NPS [5]. Such benefits include medical but he also touches upon the spiritual/recreational benefits of use of certain drugs; these are rarely part of the drug policy debate [6].…”

mentioning

confidence: 99%

See 1 more Smart Citation

A chorus of pessimism surrounding the new psychoactive substances problem

Pardo

Reuter

2016

Addiction

View full text Add to dashboard Cite

Summary statement:States are troubled by the challenges posed by NPS. A growing chorus of scholars are critical of blanket bans, such as the one adopted recently by the United Kingdom. Little is known about the consequences of the ban; good evaluations of the experiences of Ireland, Australia and the UK are urgently needed.We welcome the insightful comments to our article [1] questioning the effectiveness of the UK ban on new psychoactive substances. Each author's comments highlight the difficulties facing countries attempting to regulate the rapidly-evolving market of non-controlled psychoactives. Perhaps more troubling, the chorus of regulatory challenges from other times and places reaffirms our underlying pessimism about the solubility of the NPS problem; the available choices all leave a lot to be desired.Any effort to create a legal regulatory system is almost certain to face challenges both in court and in the market. Much more is known today about neurology, the brain, chemistry, etc. than when states first controlled 'traditional' drugs 50 or 100 years ago; this advantages the producers. Control is further complicated by the fact that, as Evans-Brown and Sedefov [2] point out, globalization makes supply of such drugs easier than before. Given these challenges more states are seriously considering blanket bans as one solution; our article failed to note that Australia imposed such a ban in 2015 [3].Yet the commenters share our apprehension about this approach. Krajewski underscores the lack of evidence of harm and the almost reactionary response of the state to ban mind-altering substances [4]. A sweeping application of the precautionary principle precludes data collection and assessment as This article is

show abstract

“…Uchtenhagen reiterates [5]. More troublesome is that a blanket ban ignores the full scope of the problem, namely the drivers behind demand for these substances.…”

mentioning

confidence: 99%

mentioning

confidence: 99%

A chorus of pessimism surrounding the new psychoactive substances problem

Pardo

Reuter

2016

Addiction

View full text Add to dashboard Cite

show abstract

Synthetic cathinones: an evolving class of new psychoactive substances

Gonçalves

Alves

Aguiar

et al. 2019

Critical Reviews in Toxicology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Which policy for new psychoactive drugs?

Cited by 2 publications

References 14 publications

A chorus of pessimism surrounding the new psychoactive substances problem

A chorus of pessimism surrounding the new psychoactive substances problem

Synthetic cathinones: an evolving class of new psychoactive substances

Contact Info

Product

Resources

About